11-08 :: August 2011
2011 third quarter ended June 30, 2011. No reve- nue was recorded for the three months ended June 30, 2011 and 2010. Total operating expenses for the quarter ended June 30, 2011 were $1.8 million, compared with $1.4 million for the quarter ended June 30, 2010. The increase in operating expenses was primarily due to increased outside lab ser- vices and contract services to support enrollment in Calando’s clinical trial and increased costs related to foreign patent filings and attorney fees associa- ted with Calando’s intellectual property portfolio. Loss from continuing operations attributable to Arrowhead for the fiscal 2011 third quarter was $1.9 million, or ($0.03) per share, compared with income of $84 thousand, or $0.00 per share in the compara- ble period in fiscal 2010.
Total net loss attributable to Arrowhead for the quar- ter ended June 30, 2011, which includes discontinu- ed operations, was $1.8 million, or ($0.03) per share based on 71.8 million weighted average shares out- standing. This compares with a total net loss attribu- table to Arrowhead of $371 thousand, or ($0.01) per share based on 64.6 million weighted average shares outstanding, for the quarter ended June 30, 2010.
ustriamicrosystems (SIX:AMS) has announced the AS1328 high-efficiency 1.5 MHz synchronous
DC-DC step-down converter. This buck regulator features efficiencies up to 96%, excellent light load efficiencies and with a quiescent current of only 25 μA. The AS1328 can deliver up to 3A of output cur-
he Bruker Nano Surfaces division (Bruker Cor- poration, NASDAQ: BRKR) has been selected
for an R&D 100 Award for AcuityXR™ enhanced- resolution microscopy technology. This novel opti- cal surface profiler mode combines patent-pending hardware and software to enable select models of
rrowhead Research Corporation (NASDAQ: ARWR) announced financial results for its fiscal
rent at output voltages as low as 0.6 V while opera- ting from an input voltage of 2.7 to 5.5 V over a -40° C to 85° C (-40° F to 185° F) temperature range.
n his National Day Rally speech, Lee Hsien Loong, Prime Minister of Singapore, expressly mentioned
Nanostart (OTCQX: NASRY) holding BioMers as an example of a successful start-up company set up by students of the National University of Singapore (NUS). “The success story of the local start-up behind the world’s first translucent dental braces shows why it is important to have a good mix of local and fo- reign students in universities here”, said the premier.
BioMers has already obtained approval for its pro- ducts in the USA, the European Union and various countries in Asia, and is in the process of marketing its products internationally. The Nanostart Singapore Early Stage Venture Fund, which Nanostart holds in conjunction with the government of Singapore, has a 24.7% stake in BioMers.